The Department of Medicine's Division of Rheumatology at the University of Massachusetts Medical School provides comprehensive care for patients with rheumatic diseases and is heavily involved in medical education and clinical research.This collection showcases journal articles and other publications and presentations written by faculty and researchers of the Division of Rheumatology.

Follow


Publications from 2017

Link

STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice, Rebecca Baum, Shrutie Sharma, Jason M. Organ, Christopher Jakobs, Veit Hornung, David B. Burr, Ann Marshak-Rothstein, Katherine A. Fitzgerald, and Ellen M. Gravallese

Link

The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis, Juergen Braun and Jonathan Kay

Link

Biosimilars: implications for rheumatoid arthritis therapy, Stanley Cohen and Jonathan Kay

Link

Clinical trials of biosimilars should become more similar, Jonathan Kay and John D. Isaacs

Link

Synovium-Derived MicroRNAs Regulate Bone Pathways in Rheumatoid Arthritis, Yukiko Maeda, Nicholas H. Farina, Melissa M. Matzelle, Paul J. Fanning, Jane B. Lian, and Ellen M. Gravallese

Link

Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent, Sudesh Pawaria, Shrutie Sharma, Rebecca Baum, Kerstin Nundel, Patricia Busto, Ellen M. Gravallese, Katherine A. Fitzgerald, and Ann Marshak-Rothstein

PDF

What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions, Sophi Tatlock, Katja Rudell, Charlotte Panter, Rob Arbuckle, Leslie R. Harrold, William J. Taylor, and Tara Symonds

Publications from 2016

Link

Synergy between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of DNase II-/-IFNaR-/- Mice, Rebecca Baum, Kerstin Nundel, Sudesh Pawaria, Shrutie Sharma, Patricia Busto, Katherine A. Fitzgerald, Ellen M. Gravallese, and Ann Marshak-Rothstein

Link

Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry, Jeffrey R. Curtis, Aseem Bharat, Lang Chen, Jeffrey D. Greenberg, Leslie R. Harrold, Joel M. Kremer, Tanya Sommers, and Dimitrios Pappas

Link

The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis, Atul Deodhar, Vibeke Strand, Jonathan Kay, and Juergen Braun

PDF

The changing landscape of biosimilars in rheumatology, Thomas Dorner, Vibeke Strand, Paul Cornes, Joao Goncalves, Laszlo Gulacsi, Jonathan Kay, Tore K. Kvien, Josef S. Smolen, Yoshiya Tanaka, and Gerd R. Burmester

Link

Brief Report: Development and Validation of a Semiautomated Method to Measure Erosion Volume in Inflammatory Arthritis by Computed Tomography Scanning, Jeffrey Duryea, Ruby Russell, Ellen M. Gravallese, Jonathan Kay, Roger Han, Bing Lu, and Daniel H. Solomon

PDF

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3), Christopher J. Edwards, Francisco J. Blanco, Jeffrey Crowley, Charles Birbara, Janusz Jaworski, Jacob Aelion, Randall M. Stevens, Adele Vessey, Xiaojiang Zhan, and Paul Bird

Link

Differential Expression of Hedgehog and Snail in Cutaneous Fibrosing Disorders: Implications for Targeted Inhibition, Amrita Goyal, Katy R. Linskey, Jonathan Kay, Lyn M. Duncan, and Rosalynn M. Nazarian

Link

Control of the innate immune response by the mevalonate pathway, Zhaozhao Jiang, Celia E. Foster, Annie S. Li, Xiaoman Zhang, Ruth M. Gavin, Sorcha D. Forde, Gail Germain, Susan B. Carpenter, Neal S. Silverman, Ellen M. Gravallese, Katherine A. Fitzgerald, Douglas T. Golenbock, and Donghai Wang

Link

Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, and Jurgen Braun

Link

Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, and Jurgen Braun

Link

Objectively Measured Physical Activity and Symptoms Change in Knee Osteoarthritis, Shao-Hsien Liu, Jeffrey B. Driban, Charles Eaton, Timothy McAlindon, Leslie R. Harrold, and Kate L. Lapane

Link

Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation, Melissa M. Matzelle, A. T. Shaw, Rebecca Baum, Yukiko Maeda Garrison, J. Li, S. Karmakar, Catherine A. Manning, N. C. Walsh, V. Rosen, and Ellen M. Gravallese

Link

RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis, William O'Brien, Brian M. Fissel, Yukiko Maeda Garrison, Jing Yan, Xianpeng Ge, Ellen M. Gravallese, Antonios O. Aliprantis, and Julia F. Charles

PDF

Endothelial-specific inhibition of NF-kappaB enhances functional haematopoiesis, Michael G. Poulos, Pradeep Ramalingam, Michael C. Gutkin, Maria Kleppe, Michael Ginsberg, Michael J. P. Crowley, Olivier Elemento, Ross L. Levine, Shahin Rafii, Jan Kitajewski, Matthew B. Greenblatt, Jae-Hyuck Shim, and Jason M. Butler

Link

Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome, Steven Schaub, Hartley M. Sirkis, and Jonathan Kay

Link

Mediators of inflammation and bone remodeling in rheumatic disease, Anita T. Shaw and Ellen M. Gravallese

PDF

IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis, Anita T. Shaw, Yukiko Maeda, and Ellen M. Gravallese

Link

Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis, Zheni Stavre, Katherine S. Upchurch, Jonathan Kay, and Ellen M. Gravallese

Link

Gadolinium-Induced Fibrosis, Derrick J. Todd and Jonathan Kay

Link

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016, Kevin Winthrop and Jonathan Kay

Publications from 2015

Link

Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts, Rebecca Baum and Ellen M. Gravallese

Link

Cutting Edge: AIM2 and Endosomal TLRs Differentially Regulate Arthritis and Autoantibody Production in DNase II-Deficient Mice, Rebecca Baum, Shrutie Sharma, Susan Carpenter, Quan-Zhen Li, Patricia Busto, Katherine A. Fitzgerald, Ann Marshak-Rothstein, and Ellen M. Gravallese

PDF

Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis, D. A. Binks, Ellen M. Gravallese, D. Bergin, R. J. Hodgson, A. L. Tan, Melissa M. Matzelle, D. McGonagle, and A. Radjenovic

PDF

Detection of IgG4-Specific Autoantibodies in Rheumatoid Arthritis Serum Samples, Azra Borogovac, Youmna Lahoud, Janice Weaver, Sheldon M. Cooper, Mercedes Rincon, Jonathan Kay, and Ellen M. Gravallese

PDF

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial, Gerd R. Burmester, William F. Rigby, Ronald F. van Vollenhoven, Jonathan Kay, Andrea Rubbert-Roth, Ariella Kelman, Sophie Dimonaco, and Nina Mitchell

PDF

Biosimilars in rheumatology: what the clinician should know, Gilberto Castaneda-Hernandez, Rodrigo Gonzalez-Ramirez, Jonathan Kay, and Morton A. Scheinberg

Link

Biosimilars in rheumatology: current perspectives and lessons learnt, Thomas Dorner and Jonathan Kay

Link

Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model, Pierre Duffau, Hanni Menn-Josephy, Carla M. Cuda, Salina Dominguez, Tamar R. Aprahamian, Amanda A. Watkins, Kei Yasuda, Paul Monach, Robert Lafyatis, Lisa M. Rice, G. Kenneth Haines 3rd., Ellen M. Gravallese, Rebecca Baum, Christophe Richez, Harris Perlman, Ramon G. Bonegio, and Ian R. Rifkin

PDF

Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry, Leslie R. Harrold, George W. Reed, Ashwini Shewade, Robert P. Magner, Katherine Saunders, Ani John, Joel M. Kremer, and Jeffrey D. Greenberg

PDF

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jurgen Braun, and Arthur Kavanaugh

Link

Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy, Zhanguo Li, Fengchun Zhang, Jonathan Kay, Kaiyin Fei, Chenglong Han, Yanli Zhuang, Zhong Wu, and Elizabeth C. Hsia

PDF

Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium, H. Matsumoto, Y. Murakami, K. Kataoka, S. Notomi, D. Mantopoulos, G. Trichonas, J. W. Miller, M. S. Gregory, B R. Ksander, Ann Marshak-Rothstein, and D. G. Vavvas

Link

Overcoming adherence issues and other barriers to optimal care in gout, Navine Nasser-Ghodsi and Leslie R. Harrold

Link

Quality indicators in rheumatoid arthritis: results from the METEOR database, Victoria Navarro-Compan, Josef S. Smolen, Tom Huizinga, Robert Landewe, Gianfranco Ferraccioli, Jose A.P. da Silva, Robert J. Moots, Jonathan Kay, and Desiree van der Heijde

Link

An unexpected role for RNA-sensing toll-like receptors in a murine model of DNA accrual, Sudesh Pawaria, Krishna L. Moody, Patricia Busto, Kerstin Nundel, Rebecca Baum, Shrutie Sharma, Ellen M. Gravallese, Katherine A. Fitzgerald, and Ann Marshak-Rothstein

PDF

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor inverted question mark inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study, Josef S. Smolen, Jonathan Kay, Mittie Doyle, Robert Landewe, Eric L. Matteson, Norman Gaylis, Jurgen Wollenhaupt, Frederick T. Murphy, Stephen Xu, Yiying Zhou, and Elizabeth C. Hsia

Publications from 2014

PDF

Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy, Herbert S. B. Baraf, Robert A. Yood, Faith D. Ottery, John S. Sundy, and Michael A. Becker

Link

Impact of inflammation on the osteoblast in rheumatic diseases, Rebecca Baum and Ellen M. Gravallese

Link

Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study, Elana J. Bernstein, Tamara Isakova, Mary E. Sullivan, Lori B. Chibnik, Myles Wolf, and Jonathan Kay

Link

Current status of nephrogenic systemic fibrosis, L. Daftari Besheli, S. Aran, K. Shaqdan, Jonathan Kay, and H. Abujudeh

PDF

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Maxime Dougados, Martin Soubrier, Anna Antunez, Peter Balint, Alejandro Balsa, Maya H. Buch, Gustavo Casado, Jacqueline Detert, Bassel El-Zorkany, Paul Emery, Najia Hajjaj-Hassouni, Masayoshi Harigai, Shue-Fen Luo, Reka Kurucz, Gabriel Maciel, Emilio Martin Mola, Carlo Maurizio Montecucco, Iain McInnes, Helga Radner, Josef S. Smolen, Yeong-Wook Song, Harald Erwin Vonkeman, Kevin Winthrop, and Jonathan Kay

Link

Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant, Anand Dusad, Michael J. Duryee, Anita T. Shaw, Lynell W. Klassen, Daniel R. Anderson, Dong Wang, Ke Ren, Ellen M. Gravallese, James R. O'Dell, Ted R. Mikuls, and Geoffrey M. Thiele

PDF

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year, Jonathan Kay, Olga Morgacheva, Susan P. Messing, Joel M. Kremer, Jeffrey D. Greenberg, George W. Reed, Ellen M. Gravallese, and Daniel E. Furst

Link

Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis, Seung-Jae Kim, Zhenlong Chen, Nathan D. Chamberlain, Abdul B. Essani, Michael V. Volin, M. Asif Amin, Suncica Volkov, Ellen M. Gravallese, Shiva Arami, William Swedler, Nancy E. Lane, Anjali Mehta, Nadera Sweiss, and Shiva Shahrara

PDF

Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial, George W. Reed, Katherine Leung, Ronald G. Rossetti, Susan Van Buskirk, John T. Sharp, and Robert B. Zurier

Link

Gadolinium-based compounds induce NLRP3-dependent IL-1beta production and peritoneal inflammation, Christian Schmidt-Lauber, Lukas Bossaller, Hani H. Abujudeh, Gregory I. Vladimer, Anette Christ, Katherine A. Fitzgerald, Eicke Latz, Ellen M. Gravallese, Ann Marshak-Rothstein, and Jonathan Kay

PDF

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN), Joachim Sieper, Jurgen Braun, Jonathan Kay, Salvatore Badalamenti, Allen R. Radin, Lixia Jiao, Stefano Fiore, Tanya Momtahen, George D. Yancopoulos, Neil Stahl, and Robert D. Inman

PDF

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study, Josef S. Smolen, Jonathan Kay, Eric L. Matteson, Robert Landewe, Elizabeth C. Hsia, Stephen Xu, Yiying Zhou, and Mittie K. Doyle

Publications from 2013

Link

Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009, Maryam M. Asgari, Jashin J. Wu, Joel M. Gelfand, Craig Salman, Jeffrey R. Curtis, Leslie R. Harrold, and Lisa J. Herrinton

Link

Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus, Lukas Bossaller, Vijay A. K. Rathinam, Ramon Bonegio, Ping-I Chang, Patricia Busto, Adam R. Wespiser, Daniel R. Caffrey, Quan-Zhen Li, Chandra Mohan, Katherine A. Fitzgerald, Eicke Latz, and Ann Marshak-Rothstein

Link

Relapsing polychondritis, Ratnesh Chopra, Nida Cahudhary, and Jonathan Kay

Link

The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis, Daniel E. Furst, Jonathan Kay, Mary Chester Wasko, Edward Keystone, Arthur Kavanaugh, Atul Deodhar, Frederick T. Murphy, Jeanette H. Magnus, Elizabeth C. Hsia, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman, and Mittie K. Doyle

Link

New developments in gout, Leslie R. Harrold

Link

Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis, Leslie R. Harrold, Becky A. Briesacher, Daniel J. Peterson, Ashley J. Beard, Jeanne M. Madden, Fang Zhang, Jerry H. Gurwitz, and Stephen B. Soumerai

Link

Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire, Leslie R. Harrold, Kathleen M. Mazor, Amarie Negron, Jessica Ogarek, Cassandra L. Firneno, and Robert A. Yood

Link

Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009, Leslie R. Harrold, Craig Salman, Stanford Shoor, Jeffrey R. Curtis, Maryam M. Asgari, Joel M. Gelfand, Jashin J. Wu, and Lisa J. Herrinton

Link

Association between anti-TNF-alpha therapy and interstitial lung disease, Lisa J. Herrinton, Leslie R. Harrold, Liyan Liu, Marsha A. Raebel, Ananse Taharka, Kevin L. Winthrop, Daniel H. Solomon, Jeffrey R. Curtis, James D. Lewis, and Kenneth G. Saag

Link

Rheumatic rarities. Preface, Jonathan Kay

Link

Rheumatoid arthritis: Erosion defined: back to basics, Jonathan Kay and Ellen M. Gravallese

Link

Biosimilars to treat inflammatory arthritis: the challenge of proving identity, Jonathan Kay and Josef S. Smolen

Link

Fibrosis-Associated Single-Nucleotide Polymorphisms in TGFB1 and CAV1 Are Not Associated With the Development of Nephrogenic Systemic Fibrosis, Long P. Le, Lilit Garibyan, Daniel Lara, Karin E. Finberg, A. John Iafrate, Lyn M. Duncan, Jonathan Kay, and Rosalynn M. Nazarian

Link

Validation of a screening instrument for nephrogenic systemic fibrosis, Xinaida Taligare Lima, Maria Beatrice Alora-Palli, Alexandra Boer Kimball, and Jonathan Kay

Link

The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells, Kerstin Nundel, Patricia Busto, Michelle E. Debatis, and Ann Marshak-Rothstein

Link

A Delphi Exercise to Identify Characteristic Features of Gout -- Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria, Rebecca L. Prowse and Leslie R. Harrold

Link

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database, Daniel Schneeberger, Alan Tyndall, Jonathan Kay, Klaus H. Sondergaard, Patricia E. Carreira, Ewa Morgiel, Katrin Deuschle, Chris T. Derk, Malgorzata Widuchowska, and Ulrich A. Walker

Link

Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist, Daniel H. Solomon, Jeremy A. Rassen, Bindee Kuriya, Lang Chen, Leslie R. Harrold, David J. Graham, James D. Lewis, Joyce Lii, Liyan Liu, Marie R. Griffin, and Jeffrey R. Curtis

Link

Rituximab biosimilars, Edward M. Vital, Jonathan Kay, and Paul Emery

Link

Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL, Nicole C. Walsh, K. A. Alexander, Catherine A. Manning, S. K. Karmakar, J. F. Wang, C. M. Weyand, Allison R. Pettit, and Ellen M. Gravallese

Publications from 2012

Link

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg, and Jerry H. Gurwitz

Link

Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure, Elana J. Bernstein, Christian Schmidt-Lauber, and Jonathan Kay

Link

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment, Timothy Beukelman, Fenglong Xie, Lang Chen, John W. Baddley, Elizabeth Delzell, Carlos G. Grijalva, James D. Lewis, Rita Ouellet-Hellstrom, Nivedita M. Patkar, Kenneth G. Saag, Kevin L. Winthrop, Jeffrey R. Curtis, SABER Collaboration, and Leslie R. Harrold

Link

Cutting Edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner, Lukas Bossaller, Ping-I Chang, Christian Schmidt-Lauber, Sandhya Ganesan, William J. Kaiser, Vijay A. K. Rathinam, Edward S. Mocarski, Deepa Subramanian, Douglas R. Green, Neal S. Silverman, Katherine A. Fitzgerald, Ann Marshak-Rothstein, and Eicke Latz

Link

Identifying patients with osteoporosis or at risk for osteoporotic fractures, Yong Chen, Leslie R. Harrold, Robert A. Yood, Terry S. Field, and Becky A. Briesacher

PDF

Malignancy validation in a United States registry of rheumatoid arthritis patients, Mark C. Fisher, Victoria Furer, Marc C. Hochberg, Jeffrey D. Greenberg, Joel M. Kremer, Jeffrey R. Curtis, George W. Reed, Leslie R. Harrold, and Daniel H. Solomon

Link

Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the ACR treatment recommendations, Leslie R. Harrold, Jeffrey R. Curtis, Daniel E. Furst, Mary Jane Bentley, Ying Shan, George W. Reed, Joel Kremer, and Jeffrey D. Greenberg

PDF

Patients' knowledge and beliefs concerning gout and its treatment: a population based study, Leslie R. Harrold, Kathleen M. Mazor, Daniel J. Peterson, Nausheen Naz, Cassandra L. Firneno, and Robert A. Yood

Link

Time trends in medication use and expenditures in older patients with rheumatoid arthritis, Leslie R. Harrold, Daniel J. Peterson, Ashley J. Beard, Jerry H. Gurwitz, and Becky A. Briesacher

Link

Association between anti-TNF-alpha therapy and all-cause mortality, Lisa J. Herrinton, Liyan Liu, Lang Chen, Leslie R. Harrold, Marsha A. Raebel, Jeffrey R. Curtis, Marie R. Griffin, Daniel H. Solomon, Kenneth G. Saag, and James D. Lewis

PDF

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012, Jonathan Kay, Brian G. Feagan, Micheal S. Guirguis, Edward C. Keystone, Agnes V. Klein, Anthony S. Lubiniecki, Diane R. Mould, Kwasi A. Nyarko, Anthony A. G. Ridgway, Maureen E. Trudeau, and Jian Wang

Link

ACR/EULAR 2010 rheumatoid arthritis classification criteria, Jonathan Kay and Katherine S. Upchurch

Link

Sensorineural hearing loss following imatinib (Gleevec) administration, Harrison W. Lin, Daniel S. Roberts, Jonathan Kay, and Konstantina M. Stankovic

Link

The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review, Alan M. Rathbun, George W. Reed, and Leslie R. Harrold

Link

A systematic review of validated methods for identifying heart failure using administrative data, Jane S. Saczynski, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Katherine S. Dodd, Robert J. Goldberg, and Jerry H. Gurwitz

Link

The advent of biosimilar therapies in rheumatology--"O brave new world", Morton A. Scheinberg and Jonathan Kay

Link

Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment, Georg Schett and Ellen M. Gravallese

PDF

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160, Josef S. Smolen, Jonathan Kay, Robert B. M. Landewe, Eric L. Matteson, Norman Gaylis, Jurgen Wollenhaupt, Frederick T. Murphy, Yiying Zhou, Elizabeth C. Hsia, and Mittie K. Doyle

Link

Dementia and risk of adverse warfarin-related events in the nursing home setting, Jennifer Tjia, Terry S. Field, Kathleen M. Mazor, Jennifer L. Donovan, Abir O. Kanaan, George W. Reed, Peter Doherty, Leslie R. Harrold, and Jerry H. Gurwitz

Link

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics, Sengwee Toh, Lingling Li, Leslie R. Harrold, Elizabeth A. Bayliss, Jeffrey R. Curtis, Liyan Liu, Lang Chen, Carlos G. Grijalva, and Lisa J. Herrinton

Link

Evolution of treatment for rheumatoid arthritis, Katherine S. Upchurch and Jonathan Kay

Publications from 2011

Link

Treating rheumatoid arthritis to target: an international initiative, Elana J. Bernstein, Jonathan Kay, and Allan Gibofsky

Link

Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry, Daniel E. Furst, Aileen L. Pangan, Leslie R. Harrold, Hong Chang, George W. Reed, Joel Kremer, and Jeffrey D. Greenberg

Link

Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations, Michael Girardi, Jonathan Kay, Dirk M. Elston, Philip E. Leboit, Ali Abu-Alfa, and Shawn E. Cowper

Link

Rheumatoid arthritis: Repair of erosion in RA--shifting the balance to formation, Ellen M. Gravallese and Nicole C. Walsh